Russia Ready to Trial Combined AstraZeneca, Sputnik V Covid-19 Vaccine In Ukraine

MOSCOW: Russia is ready to conduct clinical trials in Ukraine of a COVID-19 vaccine combining its Sputnik V with a vaccine developed by AstraZeneca together with Oxford University, the head of Russian Direct Investment Fund (RDIF) said on Saturday.

Russia’s sovereign RDIF, which is marketing the Sputnik V vaccine abroad, announced in December trials to test a combination of the AstraZeneca vaccine with the Sputnik V shot to see if this can boost the efficacy of the British drugmaker’s vaccine.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor